Determinants and prognostic significance of myocardial blood flow on cardiovascular magnetic resonance in dilated cardiomyopathy: a multicentre cohort study
The Lancet Medical Imaging & Theranostics · 2026-11 · 100030
DOI: 10.1016/j.lanmit.2026.100030 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Lancet Medical Imaging & Theranostics, 2026-11. Verfasst von Raluca Tomoaia und 15 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leeds Biomedical Research Centre, National Institute for Health Research Imperial Biomedical Research Centre, Sir Jules Thorn Charitable Trust.
Abstract (Originalsprache)
Background
Patients with dilated cardiomyopathy have altered myocardial perfusion, although the prognostic significance of perfusion abnormalities is unknown. In this study, we aimed to investigate whether myocardial perfusion reserve (MPR) assessed by stress perfusion cardiovascular magnetic resonance (CMR) in patients with dilated cardiomyopathy is independently associated with future adverse cardiovascular events.
Methods
In this multicentre cohort study, patients with dilated cardiomyopathy were recruited from three UK centres (Leeds General Infirmary, Glenfield Hospital, and Barts Heart Centre). The inclusion criteria comprised left ventricular dilatation, a left ventricular ejection fraction of less than 50%, and no clinical or CMR evidence of ischaemic heart disease. All participants underwent adenosine stress quantitative perfusion CMR between February 2018, and April 2024, to assess global stress and rest myocardial blood flow (MBF) and MPR. The primary outcome was a composite of first heart failure hospitalisation or death. Cox proportional hazards models were adjusted for age, sex, left ventricular ejection fraction, and non-ischaemic myocardial fibrosis. To identify the optimal cutoff values, a five-fold cross-validation approach was applied separately for each parameter.
Findings
Among the 549 patients enrolled, the mean age of the participants was 62 years (IQR 54–72); 349 (64%) were male participants and 200 (36%) were female. The primary endpoint occurred in 85 patients (15% of 549; 49 heart failure hospitalisations and 36 deaths) during a median follow-up of 3·1 years (IQR 1·8–4·8). Patients who met the primary outcome had lower MPR (p 0·64 mL/min per g; 2·20 [1·38–3·50], p
Förderung
- Leeds Biomedical Research Centre
- National Institute for Health Research Imperial Biomedical Research Centre
- Sir Jules Thorn Charitable Trust
- British Heart Foundation
Zitieren
APA
Tomoaia, R., Takafuji, M., Gul, U., Javed, W., Dattani, A., Marrow, B. A., Harrison, P., Pierce, I., Kellman, P., Moon, J. C., Greenwood, J. P., Ware, J. S., Treibel, T. A., Plein, S., McCann, G. P., & Swoboda, P. P. (2026). Determinants and prognostic significance of myocardial blood flow on cardiovascular magnetic resonance in dilated cardiomyopathy: a multicentre cohort study. The Lancet Medical Imaging & Theranostics, 100030. https://doi.org/10.1016/j.lanmit.2026.100030
Vancouver
Tomoaia R, Takafuji M, Gul U, Javed W, Dattani A, Marrow BA, et al. Determinants and prognostic significance of myocardial blood flow on cardiovascular magnetic resonance in dilated cardiomyopathy: a multicentre cohort study. The Lancet Medical Imaging & Theranostics. 2026:100030. doi:10.1016/j.lanmit.2026.100030
BibTeX
@article{Tomoaia2026,
author = {Tomoaia, Raluca and Takafuji, Masafumi and Gul, Uzma and Javed, Wasim and Dattani, Abhishek and Marrow, Benjamin A and Harrison, Peter and Pierce, Iain and Kellman, Peter and Moon, James C and Greenwood, John P and Ware, James S and Treibel, Thomas A and Plein, Sven and McCann, Gerry P and Swoboda, Peter P},
title = {Determinants and prognostic significance of myocardial blood flow on cardiovascular magnetic resonance in dilated cardiomyopathy: a multicentre cohort study},
journal = {The Lancet Medical Imaging & Theranostics},
year = {2026},
pages = {100030},
doi = {10.1016/j.lanmit.2026.100030}
}
EUVIMED